Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis

Table 2 Overall response

	Unmatched cNSCLC	Matched cNSCLC	uNSCLC	p-value
	(n = 131)	(n = 44)	(n = 44)	p-value
Response,				0.492
CR	0 (0)	0 (0)	2 (5)
PR	37 (28)	15 (34)	11 (25)
SD	31 (24)	12 (27)	14 (32)
PD	63 (48)	17 (39)	17 (39)
ORR	28 (21–37)	34 (20–50)	30 (17–45)	0.819
DCR	52 (43–61)	61 (45–76)	61 (45–76)	1.000

The data are expressed as number (%) and rate (95% confidence interval)
cNSCLC, common non-small cell lung cancer; CR, complete response; DCR, disease control rate; ORR, objective response rate; PD, progressive disease; PR, partial response; SD, stable disease; uNSCLC, uncommon non-small cell lung cancer

ISSN: 1471-2466